Toronto Dominion Bank’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.6M | Sell |
24,155
-3,864
| -14% | -$2.48M | 0.02% | 540 |
|
|
2025
Q4 | $19M | Sell |
28,019
-4,135
| -13% | -$2.82M | 0.03% | 469 |
|
|
2025
Q3 | $20.5M | Sell |
32,154
-4,466
| -12% | -$2.71M | 0.03% | 432 |
|
|
2025
Q2 | $19.6M | Buy |
36,620
+5,692
| +18% | +$2.72M | 0.03% | 388 |
|
|
2025
Q1 | $13M | Sell |
30,928
-2,477
| -7% | -$1.08M | 0.03% | 425 |
|
|
2024
Q4 | $13.8M | Sell |
33,405
-8,878
| -21% | -$3.89M | 0.02% | 440 |
|
|
2024
Q3 | $21.4M | Buy |
42,283
+808
| +2% | +$393K | 0.04% | 300 |
|
|
2024
Q2 | $20.2M | Sell |
41,475
-7,672
| -16% | -$3.85M | 0.03% | 309 |
|
|
2024
Q1 | $26.5M | Buy |
49,147
+951
| +2% | +$520K | 0.04% | 280 |
|
|
2023
Q4 | $26.8M | Buy |
48,196
+4,497
| +10% | +$2.11M | 0.04% | 308 |
|
|
2023
Q3 | $19.1M | Sell |
43,699
-1,244
| -3% | -$620K | 0.03% | 347 |
|
|
2023
Q2 | $22.6M | Buy |
44,943
+1,422
| +3% | +$681K | 0.03% | 340 |
|
|
2023
Q1 | $21.8M | Buy |
43,521
+5,860
| +16% | +$2.8M | 0.04% | 310 |
|
|
2022
Q4 | $15.4M | Buy |
37,661
+677
| +2% | +$263K | 0.02% | 398 |
|
|
2022
Q3 | $12M | Sell |
36,984
-6,499
| -15% | -$2.39M | 0.02% | 431 |
|
|
2022
Q2 | $15.2M | Sell |
43,483
-7,098
| -14% | -$2.89M | 0.03% | 316 |
|
|
2022
Q1 | $27.7M | Sell |
50,581
-7,050
| -12% | -$3.71M | 0.04% | 229 |
|
|
2021
Q4 | $37.9M | Buy |
57,631
+11,052
| +24% | +$6.94M | 0.05% | 218 |
|
|
2021
Q3 | $29M | Buy |
46,579
+8,952
| +24% | +$6.02M | 0.05% | 230 |
|
|
2021
Q2 | $23.8M | Sell |
37,627
-4,240
| -10% | -$2.34M | 0.04% | 281 |
|
|
2021
Q1 | $20.5M | Sell |
41,867
-11,569
| -22% | -$5.8M | 0.04% | 269 |
|
|
2020
Q4 | $26.7M | Buy |
53,436
+5,303
| +11% | +$2.37M | 0.05% | 223 |
|
|
2020
Q3 | $18.9M | Sell |
48,133
-7,881
| -14% | -$2.91M | 0.05% | 239 |
|
|
2020
Q2 | $18.5M | Sell |
56,014
-8,949
| -14% | -$2.59M | 0.05% | 268 |
|
|
2020
Q1 | $15.7M | Sell |
64,963
-15,205
| -19% | -$3.97M | 0.05% | 258 |
|
|
2019
Q4 | $20.9M | Buy |
80,168
+16,600
| +26% | +$4.37M | 0.04% | 296 |
|
|
2019
Q3 | $17.3M | Sell |
63,568
-61,606
| -49% | -$17.1M | 0.04% | 324 |
|
|
2019
Q2 | $17.2M | Buy |
125,174
+65,169
| +109% | +$16.1M | 0.04% | 317 |
|
|
2019
Q1 | $13.4M | Buy |
60,005
+8,063
| +16% | +$1.66M | 0.02% | 405 |
|
|
2018
Q4 | $9.66M | Sell |
51,942
-4,561
| -8% | -$935K | 0.02% | 418 |
|
|
2018
Q3 | $14.1M | Sell |
56,503
-826
| -1% | -$201K | 0.03% | 363 |
|
|
2018
Q2 | $12.5M | Buy |
57,329
+10,360
| +22% | +$2.13M | 0.03% | 396 |
|
|
2018
Q1 | $8.99M | Buy |
46,969
+9,395
| +25% | +$1.73M | 0.02% | 425 |
|
|
2017
Q4 | $5.88M | Buy |
37,574
+4,432
| +13% | +$698K | 0.02% | 481 |
|
|
2017
Q3 | $5.15M | Buy |
33,142
+3,289
| +11% | +$520K | 0.02% | 455 |
|
|
2017
Q2 | $4.82M | Buy |
29,853
+6,085
| +26% | +$988K | 0.02% | 454 |
|
|
2017
Q1 | $3.67M | Buy |
23,768
+22,992
| +2,963% | +$3.17M | 0.01% | 472 |
|
|
2016
Q4 | $91K | Buy |
776
+3
| +0.4% | +$342 | ﹤0.01% | 911 |
|
|
2016
Q3 | $87K | Buy |
773
+280
| +57% | +$29.5K | ﹤0.01% | 936 |
|
|
2016
Q2 | $46K | Buy |
+493
| New | +$42.3K | ﹤0.01% | 909 |
|
Other funds holding IDXX
VCM
VPM
Toronto Dominion Bank's IDXX Position: Q1 2026 in Review
Toronto Dominion Bank reduced its Idexx Laboratories (IDXX) stake by 14% in Q1 2026, selling an estimated $2.48M and leaving 24,155 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #540.
Toronto Dominion Bank first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $37.9M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Toronto Dominion Bank held 24,155 shares of Idexx Laboratories worth $13.6M as of Q1 2026.
- Toronto Dominion Bank sold 3,864 Idexx Laboratories shares in Q1 2026, an estimated $2.48M.
- Idexx Laboratories made up 0.02% of Toronto Dominion Bank's portfolio in Q1 2026, its #540 holding.
- Toronto Dominion Bank first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
- Toronto Dominion Bank's Idexx Laboratories position peaked at $37.9M in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.